F.D.A. Panel Votes Against Obesity Drug By ANDREW POLLACK A federal advisory committee voted narrowly against endorsing a drug vying to become the first new prescription medicine for obesity in more than a decade, signaling heightened concerns for possible health risks associated with a new generation of diet pills. The advisory committee to the Food [...]
Read More...
Read More...
